Chison Medical Technologies Co., Ltd. (688358.SS)
CNY 29.26
(1.95%)
CNY 29.26
(1.95%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 275.49 Million CNY | 26.02% |
| 2022 | 225.77 Million CNY | 0.82% |
| 2021 | 223.93 Million CNY | 14.77% |
| 2020 | 195.12 Million CNY | -13.37% |
| 2019 | 225.23 Million CNY | 12.66% |
| 2018 | 199.92 Million CNY | 23.87% |
| 2017 | 161.39 Million CNY | 68.14% |
| 2016 | 95.98 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 65.52 Million CNY | 3.15% |
| 2024 Q1 | 85.22 Million CNY | 99.29% |
| 2024 Q2 | 63.52 Million CNY | -25.46% |
| 2023 Q2 | 78.69 Million CNY | -21.19% |
| 2023 FY | 284.53 Million CNY | 26.02% |
| 2023 Q4 | 42.76 Million CNY | -32.35% |
| 2023 Q1 | 99.85 Million CNY | 816.38% |
| 2023 Q3 | 63.21 Million CNY | -19.66% |
| 2022 Q1 | 56.95 Million CNY | 6.44% |
| 2022 Q4 | 10.89 Million CNY | -86.21% |
| 2022 Q2 | 78.91 Million CNY | 38.55% |
| 2022 FY | 225.77 Million CNY | 0.82% |
| 2022 Q3 | 79.01 Million CNY | 0.13% |
| 2021 FY | 223.93 Million CNY | 14.77% |
| 2021 Q4 | 53.51 Million CNY | -10.93% |
| 2021 Q3 | 60.07 Million CNY | -2.18% |
| 2021 Q1 | 48.92 Million CNY | -18.01% |
| 2021 Q2 | 61.41 Million CNY | 25.53% |
| 2020 FY | 195.12 Million CNY | -13.37% |
| 2020 Q3 | 55.47 Million CNY | 45.08% |
| 2020 Q2 | 38.23 Million CNY | -8.37% |
| 2020 Q1 | 41.73 Million CNY | -47.93% |
| 2020 Q4 | 59.67 Million CNY | 7.56% |
| 2019 FY | 225.23 Million CNY | 12.66% |
| 2019 Q4 | 80.13 Million CNY | 65.92% |
| 2019 Q3 | 48.29 Million CNY | -26.52% |
| 2019 Q2 | 65.73 Million CNY | 111.6% |
| 2019 Q1 | 31.06 Million CNY | -55.58% |
| 2018 FY | 199.92 Million CNY | 23.87% |
| 2018 Q4 | 69.93 Million CNY | 0.0% |
| 2017 FY | 161.39 Million CNY | 68.14% |
| 2016 FY | 95.98 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Shenzhen Lifotronic Technology Co., Ltd. | 753.97 Million CNY | 63.46% |